Leili Baghaie

13PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer cell biologyGene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 27, 2026
Pro-Inflammatory Cytokines Differentially Induce Intercellular Tunneling Nanotube Conduits and Cellular Migration in Pancreatic, Breast, and Colorectal Cancer Cells.

Leili Baghaie, David A Bunsick, Elizabeth Skapinker

|Apr 14, 2025
Pro-Inflammatory Cytokines Transactivate Glycosylated Cytokine Receptors on Cancer Cells to Induce Epithelial-Mesenchymal Transition to the Metastatic Phenotype.

Leili Baghaie, David A Bunsick, Emilyn B Aucoin

|Feb 26, 2025
Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity.

Abdolkarim Sheikhi, Leili Baghaie, Fatemeh Rahbarizadeh

|Jan 24, 2025
Synthetic CB1 Cannabinoids Promote Tunneling Nanotube Communication, Cellular Migration, and Epithelial-Mesenchymal Transition in Pancreatic PANC-1 and Colorectal SW-620 Cancer Cell Lines.

David A Bunsick, Leili Baghaie, Yunfan Li

|Oct 25, 2024
Contemporaneous Inflammatory, Angiogenic, Fibrogenic, and Angiostatic Cytokine Profiles of the Time-to-Tumor Development by Cancer Cells to Orchestrate Tumor Neovascularization, Progression, and Metastasis.

Elizabeth Skapinker, Emilyn B Aucoin, Haley L Kombargi

|Jun 27, 2024
Artificial and Natural Sweeteners Biased T1R2/T1R3 Taste Receptors Transactivate Glycosylated Receptors on Cancer Cells to Induce Epithelial-Mesenchymal Transition of Metastatic Phenotype.

Elizabeth Skapinker, Rashelle Aldbai, Emilyn Aucoin

Pageof 3

Frequent Collaborators

13 joint publications

Myron R Szewczuk

5 joint publications

Abdulrahman M Yaish

5 joint publications

Emilyn B Aucoin

4 joint publications

David A Bunsick